What we see
The budget line you measure isn't the asset. Patents filed to cover your own roadmap quietly become patents the rest of the industry now practices.
We help operating companies, inventors, and funds convert patents into revenue — structuring the vehicle, the capital, and the risk transfer behind every monetization, from pre-suit diligence through resolution.
Every IP team can produce a number for last year's filings, annuities, and outside-counsel spend. Almost none can produce a number for what the portfolio is worth to anyone outside the company. The first is a cost. The second is the question we get hired to answer.
The budget line you measure isn't the asset. Patents filed to cover your own roadmap quietly become patents the rest of the industry now practices.
Defensive thinking buries commercial value. Because nobody is paid to look outward, the portfolio's commercial reach is rarely measured — and that reach is where the value lives.
We map the estate against external markets, size opportunity conservatively against verifiable third-party use, and structure the path to capture it.
Monetization is a sequence of decisions — what to assert, how to structure it, who funds it, and how the risk is carried. We run every step.
We map the portfolio against external markets rather than your own product lines, building the diligence, claim-chart, and damages analyses that tell us — conservatively, against verifiable third-party use — where real value sits.
Inward-facing patents protect your roadmap; outward-facing patents read on what other companies actually ship — and that is where the leverage is. We sort on adoption, remaining term, family depth, and reach beyond the U.S.
The structure dictates everything downstream — who pays, who carries countersuit exposure, how fast revenue arrives, and how it looks on the financial statements. We build either and are direct about which fits.
Where a vehicle is the right call, we structure a dedicated patent holding company to capitalize the portfolio — ringfencing the assets for licensing, financing, and outside-investor participation, and isolating countersuit risk away from the operating company.
We sit at the table with leading patent litigation funders, aligning case selection, fees, and waterfall economics. The capital plan shows up at the start of the engagement, not in month nine.
Judgment-preservation and litigation insurance hedge against outcome volatility — and, just as importantly, unlock financing and securitization that wouldn't otherwise price.
Leverage compounds at each milestone — complaint filed, claim construction won, IPR survived, summary judgment held. Each step thins the defendant's options and shifts the economic conversation toward a license.
We negotiate economics that survive contact with reality, so the patent owner sees meaningful proceeds at the first license — not only after the funder is fully made whole. Misaligned waterfalls are how good cases turn into bad deals.
K2K builds either. In-house fits when you already operate a licensing function and can carry the litigation budget. A vehicle fits when you would rather convert IP into capital without absorbing the legal, financial, or reputational drag of running the campaign yourself.
One firm, three functions — patent counsel, licensing platform, and capital interface — so the operating company can stay focused on its business while the portfolio earns.
Dedicated vehicles that capitalize a portfolio — ringfencing assets for licensing, financing, and outside-investor participation, with countersuit exposure isolated from the operating business.
Capital-backed enforcement structured with leading patent litigation funders, aligning case selection, fees, and waterfall economics from day one.
Litigation and judgment-preservation insurance that de-risks monetization — unlocking financing, securitization, and recovery against outcome volatility.
Tell us about the estate. We'll tell you candidly whether there's a campaign worth running — and how it would be structured, funded, and de-risked.